SELLAS Life Sciences Group, Inc.SLSNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-5.56%
↑ 79% above average
Average (9y)
-26.38%
Historical baseline
Range
High:-2.35%
Low:-62.62%
CAGR
+10.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -5.56% | +60.1% |
| 2023 | -13.93% | +77.5% |
| 2022 | -61.84% | -103.5% |
| 2021 | -30.39% | -35.2% |
| 2020 | -22.48% | -26.2% |
| 2019 | -17.82% | +15.2% |
| 2018 | -21.01% | +66.4% |
| 2017 | -62.62% | -142.4% |
| 2016 | -25.84% | -998.3% |
| 2015 | -2.35% | - |